ADIAL PHARMACEUTICALS, INC. - 8-K Filing
Adial Pharmaceuticals rebrands to Azora Therapeutics, increases authorized shares to 500 million, and appoints new executive leadership. (Items: 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi, 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, 5.07 Submission of Matters to a Vote of Security Holders, 7.01 Regulation FD Disclosure)
Tickers: $ADIL
Read the full article at SEC EDGAR
Part of the story Cardiff Oncology, Inc. - 8-K Filing (3 articles)